Cargando…

Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique

BACKGROUND: Single-dose nevirapine (sd-NVP) has been the main option for prevention of mother-to-child transmission (PMTCT) of HIV-1 in low-resource settings. However, sd-NVP can induce the selection of HIV-1 resistant mutations in mothers and infants. In Mozambique, there are limited data regarding...

Descripción completa

Detalles Bibliográficos
Autores principales: Antunes, Francisco, Zindoga, Pereira, Gomes, Perpétua, Augusto, Orvalho, Mahumane, Isabel, Veloso, Luís, Valadas, Emília, Camacho, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498634/
https://www.ncbi.nlm.nih.gov/pubmed/26161559
http://dx.doi.org/10.1371/journal.pone.0131994
_version_ 1782380650385375232
author Antunes, Francisco
Zindoga, Pereira
Gomes, Perpétua
Augusto, Orvalho
Mahumane, Isabel
Veloso, Luís
Valadas, Emília
Camacho, Ricardo
author_facet Antunes, Francisco
Zindoga, Pereira
Gomes, Perpétua
Augusto, Orvalho
Mahumane, Isabel
Veloso, Luís
Valadas, Emília
Camacho, Ricardo
author_sort Antunes, Francisco
collection PubMed
description BACKGROUND: Single-dose nevirapine (sd-NVP) has been the main option for prevention of mother-to-child transmission (PMTCT) of HIV-1 in low-resource settings. However, sd-NVP can induce the selection of HIV-1 resistant mutations in mothers and infants. In Mozambique, there are limited data regarding the profile of NVP resistance associated mutations (RAM) in the context of PMTCT. OBJECTIVES: To assess the prevalence and the factors associated with NVP RAM among children born to HIV-1 infected mothers enrolled in the PMTCT programme adopted in Mozambique. METHODS: One hundred and fifty seven children aged 6 to 48 weeks were sequentially included (July 2011 to March 2012) at four centres in Maputo. Genotyping of RAM was performed in samples with HIV-1 RNA≥ 100 copies/μL (Viroseq). Sequencing was performed with ABI 3100 (Applied Biosystems). Logistic regression modelling was undertaken to identify the factors associated with NVP RAM. RESULTS: Seventy-nine children had their samples genotyped. Their median age was 7.0 (3–12) months and 92.4% received prophylaxis with sd-NVP at birth plus daily NVP. 35.4% of mothers received antiretrovirals (ARVs) for PMTCT. ARV RAM were detected in 43 (54.4%) of the children. 45.6% of these children had at least one NVP RAM. The most common mutations associated with NVP resistance were K103N (n = 16) and Y181C (n = 15). NVP RAM was significantly associated with mother exposure to PMTCT (crude odds ratio [OR] 30.3, 95% CI 4.93–186.34) and with mother’s CD4 count < 350 cells/mm(3) (crude OR 3.08, 95% CI 1.02–9.32). In the multivariable analysis the mother’s exposure to PMTCT was the only variable significantly associated with NVP RAM (adjusted OR 48.65, 95% CI 9.33–253.66). CONCLUSIONS: We found a high prevalence of NVP RAM among children who were exposed to the drug regimen for PMTCT in Mozambique. The mothers’ exposure to PMTCT significantly increased the risk of NVP RAM.
format Online
Article
Text
id pubmed-4498634
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44986342015-07-17 Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique Antunes, Francisco Zindoga, Pereira Gomes, Perpétua Augusto, Orvalho Mahumane, Isabel Veloso, Luís Valadas, Emília Camacho, Ricardo PLoS One Research Article BACKGROUND: Single-dose nevirapine (sd-NVP) has been the main option for prevention of mother-to-child transmission (PMTCT) of HIV-1 in low-resource settings. However, sd-NVP can induce the selection of HIV-1 resistant mutations in mothers and infants. In Mozambique, there are limited data regarding the profile of NVP resistance associated mutations (RAM) in the context of PMTCT. OBJECTIVES: To assess the prevalence and the factors associated with NVP RAM among children born to HIV-1 infected mothers enrolled in the PMTCT programme adopted in Mozambique. METHODS: One hundred and fifty seven children aged 6 to 48 weeks were sequentially included (July 2011 to March 2012) at four centres in Maputo. Genotyping of RAM was performed in samples with HIV-1 RNA≥ 100 copies/μL (Viroseq). Sequencing was performed with ABI 3100 (Applied Biosystems). Logistic regression modelling was undertaken to identify the factors associated with NVP RAM. RESULTS: Seventy-nine children had their samples genotyped. Their median age was 7.0 (3–12) months and 92.4% received prophylaxis with sd-NVP at birth plus daily NVP. 35.4% of mothers received antiretrovirals (ARVs) for PMTCT. ARV RAM were detected in 43 (54.4%) of the children. 45.6% of these children had at least one NVP RAM. The most common mutations associated with NVP resistance were K103N (n = 16) and Y181C (n = 15). NVP RAM was significantly associated with mother exposure to PMTCT (crude odds ratio [OR] 30.3, 95% CI 4.93–186.34) and with mother’s CD4 count < 350 cells/mm(3) (crude OR 3.08, 95% CI 1.02–9.32). In the multivariable analysis the mother’s exposure to PMTCT was the only variable significantly associated with NVP RAM (adjusted OR 48.65, 95% CI 9.33–253.66). CONCLUSIONS: We found a high prevalence of NVP RAM among children who were exposed to the drug regimen for PMTCT in Mozambique. The mothers’ exposure to PMTCT significantly increased the risk of NVP RAM. Public Library of Science 2015-07-10 /pmc/articles/PMC4498634/ /pubmed/26161559 http://dx.doi.org/10.1371/journal.pone.0131994 Text en © 2015 Antunes et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Antunes, Francisco
Zindoga, Pereira
Gomes, Perpétua
Augusto, Orvalho
Mahumane, Isabel
Veloso, Luís
Valadas, Emília
Camacho, Ricardo
Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique
title Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique
title_full Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique
title_fullStr Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique
title_full_unstemmed Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique
title_short Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique
title_sort development of nevirapine resistance in children exposed to the prevention of mother-to-child hiv-1 transmission programme in maputo, mozambique
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498634/
https://www.ncbi.nlm.nih.gov/pubmed/26161559
http://dx.doi.org/10.1371/journal.pone.0131994
work_keys_str_mv AT antunesfrancisco developmentofnevirapineresistanceinchildrenexposedtothepreventionofmothertochildhiv1transmissionprogrammeinmaputomozambique
AT zindogapereira developmentofnevirapineresistanceinchildrenexposedtothepreventionofmothertochildhiv1transmissionprogrammeinmaputomozambique
AT gomesperpetua developmentofnevirapineresistanceinchildrenexposedtothepreventionofmothertochildhiv1transmissionprogrammeinmaputomozambique
AT augustoorvalho developmentofnevirapineresistanceinchildrenexposedtothepreventionofmothertochildhiv1transmissionprogrammeinmaputomozambique
AT mahumaneisabel developmentofnevirapineresistanceinchildrenexposedtothepreventionofmothertochildhiv1transmissionprogrammeinmaputomozambique
AT velosoluis developmentofnevirapineresistanceinchildrenexposedtothepreventionofmothertochildhiv1transmissionprogrammeinmaputomozambique
AT valadasemilia developmentofnevirapineresistanceinchildrenexposedtothepreventionofmothertochildhiv1transmissionprogrammeinmaputomozambique
AT camachoricardo developmentofnevirapineresistanceinchildrenexposedtothepreventionofmothertochildhiv1transmissionprogrammeinmaputomozambique